Assoc. Prof. Ramzi A. Ajjan
United Kingdom

RA Ajjan (FRCP, MMed.Sci, PhD) is an Associate Professor/Consultant in Diabetes and Endocrinology at Leeds University and Leeds Teaching Hospitals Trust. He obtained his PhD from the University of Sheffield and completed his clinical training in Diabetes and Endocrinology at Leeds Teaching Hospitals. Dr. Ajjan was successful at obtaining a Clinician Scientist Award from the NIHR in 2005 and developed a spectrum of basic, translational and clinical research studies. His work collectively aims to reduce atherothrombotic complications in individuals with diabetes, which remain the main cause of mortality in this population. He described three new mechanisms for increased thrombosis risk in diabetes, with both hypo and hyperglycaemia having key roles. Moreover, he has shown a close relationship between hypoglycaemia and adverse clinical outcome, with enhanced thrombosis risk representing a potential link. He has over 140 publications including original articles, reviews and book chapters. His clinical practice concentrates on complicated type 2 diabetes subjects with established cardiovascular disease and young adults with diabetes.

He is the R&D lead for Diabetes and Endocrinology at Leeds Teaching Hospitals and the lead for first year medical student teaching in Diabetes Endocrinology at Leeds University. He is an Associate Editor of Diabetes and Vascular Disease Research and co-lead of the regional Clinical Research Network in Diabetes, Endocrine and Metabolic conditions.


Diabetes is associated with an increased risk of cardiovascular events and a prothrombotic environment has been implicated as one of the mechanisms involved. Anti-platelet agents are regularly used for the prevention of vascular ischaemic events in diabetes but the best management strategy in this population is not entirely clear.

The current presentation will review the latest evidence in relation to anti-platelet therapy in diabetes, covering both primary and secondary prevention. Moreover, the session will provide a practical guide for the management of the prothrombotic environment in diabetes, helping the health care professional to make clinical decisions tailored to the need of each individual.

ADIT Secretariat


Robova cesta 6

1360 Vrhnika